Trial intelligence / Profile preview

Remifentanil infusion effect on oocyte retrieval

IRCT201611177013N15Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of remifentanil in None, sponsored by Tabriz University of Medical Sciences. Started Dec 2016; status: completed.

02

Drugs

remifentanil

Beyond the preview

Go deeper on IRCT201611177013N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201611177013N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call